BC
SVRA icon

Birchview Capital’s Savara SVRA Stock Holding History

Birchview Capital’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
+80,000
New +$429K 0.23% 52

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Birchview Capital's SVRA Position: Q2 2026 in Review

Birchview Capital opened a new position in Savara (SVRA) in Q2 2026: 80,000 shares worth $493K. The stake represents 0.23% of the portfolio and ranks #52 among its holdings.

181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Birchview Capital held 80,000 shares of Savara worth $493K as of Q2 2026.
  • Savara was a new Birchview Capital position in Q2 2026.
  • Savara made up 0.23% of Birchview Capital's portfolio in Q2 2026, its #52 holding.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.